[1]
Bilski J, Wojcik D, Danielak A, et al. Alternative Therapy in the Prevention of Experimental and Clinical InflammatoryBowel Disease. Impact of Regular Physical Activity, Intestinal Alkaline Phosphatase and Herbal Products. Curr Pharm Des 2020; 26(25): 2936-50.
[2]
De Musis C, Granata L, Dellio M, Miranda A, Gravina AG, Romano M. Inflammatory Bowel Diseases: The Role of Gut Microbiota. Curr Pharm Des 2020; 26(25): 2951-61.
[3]
Filaretova L, Podvigina T, Yarushkina N. Physiological and Pharmacological Effects of Glucocorticoids on the Gastrointestinal Tract. Curr Pharm Des 2020; 26(25): 2962-70.
[4]
Park JM, Lee HJ, Sikiric P, et al. BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection. Curr Pharm Des 2020; 26(25): 2971-81.
[5]
Ray A, Gulati K, Henke P. Stress Gastric Ulcers and Cytoprotective Strategies: Perspectives and Trends. Curr Pharm Des 2020; 26(25): 2982-90.
[6]
Sikiric P, Drmic D, Sever M, et al. Fistulas Healing. Stable Gastric Pentadecapeptide BPC 157 Therapy. Curr Pharm Des 2020; 26(25): 2991-3000.
[7]
Takeuchi K, Ohashi Y, Amagase K. Roles of Up-Regulated Expression of ASIC3 in Sex Difference of Acid-Induced Duodenal HCO3- Responses. Curr Pharm Des 2020; 26(25): 3001-9.
[8]
Wood JD. Serotonergic Integration In the Intestinal Mucosa. Curr Pharm Des 2020; 26(25): 3010-4.
[9]
Keremi B, Marta K, Farkas K, et al. Effects of Chlorine Dioxide on Oral Hygiene - A Systematic Review and Meta-analysis. Curr Pharm Des 2020; 26(25): 3015-25.